Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals), By Region, And Segment Forecasts, 2025-2034

Global Digital Pathology Market Size is valued at USD 1,173.9 Million in 2024 and is predicted to reach USD 3,981.2 Million by the year 2034 at a 13.1% CAGR during the forecast period for 2025-2034.

Digital pathology is the interpretation and administration of pathology data derived from digitalized glass slides. One of the most popular solutions for regular diagnostics and medication development has been digital pathology. Due to its many advantages, such as real-time sharing of streaming sites and digital photographs, digital pathology has grown. Integration of artificial intelligence (AI) with clinical data, machine learning (ML) allows for picture evaluation that goes beyond what is possible with classical histology. 

Additionally, the launch of cloud-based technology allows the storage of digital slides associated with protected access to pathologists, which is predicted to contribute to the digital pathology market growth in the coming years. However, the high cost of these systems, coupled with the challenge of an absence of skilled personnel to operate digital pathology systems, is expected to limit the adoption of these systems.

The use of AI in healthcare is expanding as there is an increasing emphasis on enhancing patient care by applying AI to various healthcare services, such as pathological diagnosis. The growing demand for researcher cooperation and the expansion of digital documentation across all scientific disciplines drives the increased acceptance. The growing adoption of healthcare IT systems further boosts the digital pathology market demand. 

Recent Developments:

• In March 2022-Ion Torrent Genexus Dx Integrated Sequencer, an automated next-generation sequencing (NGS) platform for use in clinical laboratories and to conduct diagnostic and clinical research, was introduced by Thermo Fisher Scientific, Inc. with the CE-IVD marking.

• In April 2022-A contract between the Catalan Health Institute and 3DHISTECH Ltd. was signed. This plan was implemented to introduce digital pathology tools across an eight-hospital network. 

Competitive Landscape:

Some of the digital pathology market players are:

• Biosystems (US)
• Koninklijke Philips N.V. (Netherlands)
• Hamamatsu Photonics (Japan)
• Hoffmann-La Roche Ltd. (Switzerland)
• 3DHISTECH (Hungary)
• Apollo Enterprise Imaging (US)
• XIFIN, Inc. (US)
• Huron Digital Pathology (Canada)
• Visiopharm A/S (Denmark)
• Aiforia Technologies Oy (Finland)
• Akoya Biosciences (US)
• Corista (US)
• Indica Labs (US)
• Objective Pathology Services (Canada)
• Sectra AB (Sweden)
• OptraSCAN (US)
• Glencoe Software (US)
• KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China)
• Inspirata, Inc. (US)
• PathAI (US)
• Proscia Inc. (US)
• Kanteron Systems (Spain)
• Mikroscan Technologies (US)
• Motic (US)
• Paige (US)

Market Segmentation:

The digital pathology market is segmented on a product, software, type, application and end users. Based on product, the market is divided into scanners, brightfield and other scanners. The market is segmented by software, integrated software, standalone software and storage systems. By type, the market is segmented into human pathology and veterinary pathology. By application, the market is segmented into drug discovery, disease diagnosis, training & education. By end users, the digital pathology market is segmented into pharmaceutical & biotechnology companies, hospitals and reference laboratories and academic & research institutes.

Based On Application, The Disease Diagnosis Segment Is A Major Contributor To The Digital Pathology Market

The disease diagnosis category is expected to hold a major global market share in 2024. Since it helps identify and comprehend the causes of diseases, digital diagnostics is essential in diagnosing many chronic diseases. The usage of digital pathology for routine diagnoses is rapidly expanding. The COVID-19 epidemic and its related social isolation barriers increased the demand for digital pathology. The market is significantly expanding due to the rising prevalence of cardiovascular illnesses and the growing demand for novel technologies to diagnose these conditions. Therefore, it is anticipated that the disease diagnosis segment will experience a significant increase over the projected period due to reasons such as the rising burden of infectious and chronic diseases and the integration of digital pathology.

Hospitals And Reference Laboratories Segment Witness Growth At A Rapid Rate

The hospitals and reference laboratories segment is projected to grow rapidly in the global digital pathology market. The increase in hospital admissions for the treatment of chronic illnesses and the expansion of digital pathology tools and systems in the healthcare industry in industrialized nations. The market is also anticipated to increase due to strategic partnerships between hospitals and major market participants for the introduction of cutting-edge products. Clinical decision support systems and other AI-based solutions help hospitals streamline workflow procedures and improve medical care, which improves the patient experience. 

The North American Digital Pathology Market Holds A Significant Regional Revenue Share

North America is growing at a whopping rate in the global Digital Pathology market and undergoing a rapid transformation over the upcoming years. This is due to the rapidly rising occurrence of cancer, the launch of favorable reimbursement policies, increasing demand for quality diagnostics, and the increasing government initiatives by the government of Canada and the US are the essential elements driving the market growth in North America in forthcoming years.

Moreover, the Asia Pacific region is projected to grow rapidly in the global digital pathology market. The expansion can be linked to investments in the medical sector, untapped prospects in the Asia Pacific, and the increased adoption of digital imaging in emerging nations. Due to the rising incidence of cancer, which affects a major portion of the population, the healthcare sector in the Asia Pacific has significantly impacted the market. In addition, the region's market is anticipated to rise due to increased demand for novel treatment choices, improved patient care facilities, and lower laboratory costs.

Digital Pathology Market Report Scope: